— Know what they know.
Not Investment Advice
Also trades as: 0R2S.L (LSE) · $vol 1M · SYK.DE (XETRA) · $vol 0M · SYK.TO (TSX) · $vol 0M

SYK NYSE

Stryker Corporation
1W: -0.9% 1M: +9.9% 3M: -14.4% YTD: -13.4% 1Y: -21.0% 3Y: +15.6% 5Y: +16.1%
$301.50
-4.63 (-1.51%)
 
Weekly Expected Move ±3.9%
$283 $295 $307 $319 $331
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 76 · $115.6B mcap · 348M float · 0.758% daily turnover · Short 58% of daily vol
Credit Risk of going bust: lower than 80% of companies Debt: 11.4% of company value Bonds: $342.4M held by 263 funds, 53 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.73 (down 99.1%), Stryker Corporation would be worth roughly what it owes.
Total debt $14.94B against a stock market value of $115.65B.
Distance to default 9.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $7.85B (short-term plus half of long-term), stock volatility 30.4%; Altman Z 4.64. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
63.7 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 11.6%  ·  5Y Avg: 10.0%
Cost Advantage
71
Intangibles
59
Switching Cost
58
Network Effect
55
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SYK has a Narrow competitive edge (63.7/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 11.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$310
Low
$358
Avg Target
$420
High
Based on 12 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 36Hold: 15Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$357.83
Analysts12
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-12 BTIG Ryan Zimmerman $358 $316 -42 +12.9% $279.83
2026-10-06 Barclays — $394 $375 -19 +34.6% $278.50
2026-10-06 Truist Financial — $330 $310 -20 +10.6% $280.23
2026-09-30 Stifel Nicolaus — $245 $330 +85 +18.3% $278.86
2026-09-18 Canaccord Genuity — $400 $385 -15 +37.4% $280.14
2026-09-09 BMO Capital Joanne Wuensch $369 $317 -52 +14.1% $277.89
2026-09-09 Wells Fargo Larry Biegelsen $286 $348 +62 +25.9% $276.43
2026-07-31 RBC Capital Shagun Singh $435 $420 -15 +30.8% $321.08
2026-07-31 Raymond James — $418 $370 -48 +14.7% $322.69
2026-07-31 BTIG Ryan Zimmerman $371 $358 -13 +11.1% $322.13
2026-07-31 Piper Sandler — $420 $390 -30 +11.9% $348.37
2026-07-31 Wolfe Research — Initiated $375 — +7.6% $348.37
2026-07-13 BTIG — $379 $371 -8 +12.5% $329.78
2026-07-09 Argus Research — $450 $370 -80 +12.5% $328.79
2026-07-08 BMO Capital — Initiated $369 — +12.9% $326.85
2026-07-06 Evercore ISI — $355 $350 -5 +9.6% $319.22
2026-06-05 Leerink Partners Mike Kratky $285 $407 +122 +35.1% $301.21
2026-05-04 Truist Financial Richard Newitter $400 $330 -70 +12.5% $293.44
2026-05-04 Barclays Matt Miksic $469 $394 -75 +33.7% $294.73
2026-05-01 Goldman Sachs David Roman $399 $361 -38 +22.5% $294.73
2026-05-01 Bernstein — $465 $410 -55 +35.6% $302.38
2026-05-01 Robert W. Baird — $437 $385 -52 +25.1% $307.87
2026-05-01 Evercore ISI — $390 $355 -35 +15.2% $308.17
2026-05-01 BTIG — $412 $379 -33 +20.2% $315.18
2026-05-01 Needham — $454 $418 -36 +32.6% $315.18
2026-05-01 Deutsche Bank — $285 $315 +30 -0.1% $315.18
2026-03-04 Jefferies Matthew Taylor Initiated $465 — +21.8% $381.89
2026-02-24 UBS — $408 $400 -8 +4.8% $381.83
2026-02-02 Barclays — $257 $469 +212 +26.9% $369.56
2026-01-30 Needham Mike Matson $448 $454 +6 +24.2% $365.62
2026-01-30 Robert W. Baird — Initiated $437 — +18.4% $369.02
2026-01-30 BTIG Ryan Zimmerman $403 $412 +9 +16.3% $354.30
2026-01-09 Bernstein Lee Hambright $450 $465 +15 +26.6% $367.21
2026-01-09 Goldman Sachs — $422 $399 -23 +8.7% $367.21
2026-01-06 Raymond James — Initiated $418 — +19.8% $348.79
2026-01-05 Evercore ISI — $405 $390 -15 +12.2% $347.69
2025-11-14 Truist Financial Richard Newitter $392 $400 +8 +9.2% $366.38
2025-11-14 RBC Capital Shagun Singh $272 $435 +163 +19.1% $365.14
2025-11-14 Needham Mike Matson $392 $448 +56 +20.0% $373.42
2025-11-03 Truist Financial — $407 $392 -15 +9.1% $359.36
2025-10-31 Evercore ISI — $410 $405 -5 +13.3% $357.60
2025-10-15 Truist Financial — $415 $407 -8 +9.7% $370.88
2025-10-13 UBS — $267 $408 +141 +11.9% $364.60
2025-10-07 Evercore ISI — Initiated $410 — +11.9% $366.28
2025-09-18 Redburn Partners — Initiated $420 — +11.5% $376.80
2025-08-04 Truist Financial — $409 $415 +6 +8.8% $381.49
2025-05-05 Bernstein Lee Hambright $295 $450 +155 +18.0% $381.36
2025-04-14 BTIG Ryan Zimmerman $394 $403 +9 +14.0% $353.42
2025-03-04 Goldman Sachs — $372 $422 +50 +8.2% $389.92
2025-02-03 Argus Research David Toung $380 $450 +70 +15.0% $391.14

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SYK receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-14 B B+
2026-08-10 B+ B
2026-07-31 B B+
2026-05-04 B+ B
2026-04-30 B B+
2026-03-24 B- B
2026-01-03 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 74 Grade A+
Profitability
72
Balance Sheet
63
Earnings Quality
78
Growth
64
Value
52
Momentum
90
Safety
100
Cash Flow
70
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SYK scores highest in Safety (100/100) and lowest in Value (52/100). An overall grade of A+ places SYK among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.79
Safe Zone
Piotroski F-Score
9/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-2.74
Unlikely Manipulator
Ohlson O-Score
-9.18
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 81.0/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.48x
Accruals: -3.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SYK scores 4.79, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SYK scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SYK's score of -2.74 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SYK's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SYK receives an estimated rating of AA- (score: 81.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SYK's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
30.99x
PEG
1.14x
P/S
4.48x
P/B
4.82x
P/FCF
25.85x
P/OCF
22.00x
EV/EBITDA
19.87x
EV/Revenue
5.15x
EV/EBIT
24.42x
EV/FCF
28.28x
Earnings Yield
3.07%
FCF Yield
3.87%
Shareholder Yield
1.21%
Graham Number
$116.22
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 31.0x earnings, SYK commands a growth premium. Graham's intrinsic value formula yields $116.22 per share, 159% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.724
NI / EBT
×
Interest Burden
0.945
EBT / EBIT
×
EBIT Margin
0.211
EBIT / Rev
×
Asset Turnover
0.548
Rev / Assets
×
Equity Multiplier
2.086
Assets / Equity
=
ROE
16.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SYK's ROE of 16.5% is driven by Asset Turnover (0.548), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
11.04%
Fair P/E
30.58x
Intrinsic Value
$295.38
Price/Value
1.07x
Margin of Safety
-6.59%
Premium
6.59%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SYK's realized 11.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SYK trades at a 7% premium to its adjusted intrinsic value of $295.38, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 30.6x compares to the current market P/E of 31.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$301.50
Median 1Y
$304.36
5th Pctile
$188.53
95th Pctile
$491.10
Ann. Volatility
29.4%
Analyst Target
$357.83
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kevin A. Lobo
Chair, Chief Executive Officer and President
$1,491,667 $9,764,136 $21,401,495
Spencer S. Stiles
Group President, Orthopaedics
$792,500 $2,685,078 $6,328,959
J. Andrew Pierce
Group President, MedSurg and Neurotechnology
$792,500 $2,685,078 $6,323,107
Preston W. Wells
Vice President, Chief Financial Officer
$653,431 $1,841,377 $4,410,422
Viju S. Menon
Group President, Global Quality and Operations
$675,000 $1,647,444 $4,235,809
Glenn S. Boehnlein
Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer
$800,000 $— $1,893,046

CEO Pay Ratio

139:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $21,401,495
Avg Employee Cost (SGA/emp): $154,482
Employees: 56,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
56,000
+5.7% YoY
Revenue / Employee
$448,500
Rev: $25,116,000,000
Profit / Employee
$57,964
NI: $3,246,000,000
SGA / Employee
$154,482
Avg labor cost proxy
R&D / Employee
$28,250
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 14.0% 14.3% 14.1% 14.1% 16.0% 15.0% 16.4% 16.4% 15.0% 18.0% 18.6% 18.6% 18.9% 15.3% 14.3% 14.3% 14.0% 15.1% 15.2% 16.5% 16.51%
ROA 5.7% 5.8% 5.8% 6.0% 7.0% 6.6% 7.2% 7.4% 7.0% 8.2% 8.8% 9.0% 8.8% 7.2% 6.7% 6.8% 6.5% 7.1% 7.2% 7.9% 7.91%
ROIC 12.9% 12.9% 11.6% 11.4% 11.8% 11.6% 11.7% 11.6% 11.4% 12.9% 12.8% 12.9% 13.1% 14.3% 12.5% 13.1% 13.1% 12.2% 11.1% 11.6% 11.63%
ROCE 7.4% 8.7% 8.3% 8.5% 9.6% 8.8% 9.6% 10.2% 10.5% 11.5% 12.1% 12.5% 11.6% 9.9% 8.8% 9.0% 8.8% 11.7% 12.3% 13.2% 13.20%
Gross Margin 63.0% 62.3% 60.6% 59.8% 59.2% 59.1% 60.1% 60.8% 61.5% 61.1% 60.9% 61.3% 61.8% 62.0% 62.7% 62.3% 63.6% 65.2% 63.3% 68.3% 68.27%
Operating Margin 21.5% 23.2% 18.3% 20.2% 19.0% 23.0% 18.0% 21.3% 20.2% 24.5% 19.1% 21.4% 22.0% 25.8% 20.1% 22.6% 18.7% 27.3% 15.5% 25.2% 25.18%
Net Margin 10.5% 14.1% 7.6% 14.6% 18.2% 10.8% 12.4% 14.8% 14.1% 19.7% 15.0% 15.2% 15.2% 8.5% 11.1% 14.7% 14.2% 11.8% 12.4% 19.4% 19.37%
EBITDA Margin 17.5% 28.3% 14.7% 21.7% 23.8% 19.5% 19.6% 23.2% 23.0% 25.4% 22.6% 23.2% 23.9% 12.3% 17.7% 24.4% 22.5% 28.3% 21.6% 30.4% 30.37%
FCF Margin 18.1% 16.0% 14.1% 11.7% 11.2% 11.0% 12.0% 12.4% 12.9% 15.3% 13.6% 13.1% 14.6% 15.4% 15.4% 16.9% 16.7% 17.1% 18.1% 18.2% 18.20%
OCF Margin 21.0% 19.1% 17.3% 15.1% 14.6% 14.2% 15.1% 15.5% 16.0% 18.1% 16.6% 16.0% 17.5% 18.8% 18.5% 20.0% 19.8% 20.1% 21.3% 21.4% 21.38%
ROE 3Y Avg snapshot only 15.59%
ROE 5Y Avg snapshot only 15.13%
ROA 3Y Avg snapshot only 7.63%
ROIC 3Y Avg snapshot only 8.73%
ROIC Economic snapshot only 10.73%
Cash ROA snapshot only 11.53%
Cash ROIC snapshot only 15.58%
CROIC snapshot only 13.26%
NOPAT Margin snapshot only 15.96%
Pretax Margin snapshot only 19.92%
R&D / Revenue snapshot only 6.42%
SGA / Revenue snapshot only 33.99%
SBC / Revenue snapshot only 0.97%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 50.94 49.35 48.95 35.38 30.55 38.60 40.66 42.32 39.85 35.75 40.45 37.61 38.45 46.14 50.09 52.27 48.57 41.85 38.06 32.59 30.986
P/S Ratio 5.81 5.75 5.66 4.17 4.18 4.93 5.64 5.89 5.18 5.52 6.49 6.06 6.28 6.11 6.17 6.40 5.86 5.41 5.03 4.70 4.476
P/B Ratio 6.83 6.61 6.56 4.69 4.56 5.48 6.32 6.60 5.75 6.09 7.09 6.56 6.85 6.69 6.84 7.20 6.56 6.06 5.53 5.07 4.820
P/FCF 32.09 35.94 40.21 35.58 37.25 44.70 47.11 47.43 40.11 36.08 47.57 46.26 43.07 39.60 40.03 37.90 35.10 31.72 27.78 25.85 25.846
P/OCF 27.65 30.16 32.73 27.60 28.64 34.69 37.27 37.90 32.33 30.49 39.18 37.97 35.96 32.55 33.40 32.00 29.58 26.93 23.63 22.00 21.996
EV/EBITDA 33.82 30.04 31.11 23.57 21.72 27.88 29.73 30.33 26.95 26.29 29.70 27.83 28.58 32.52 35.98 36.27 33.70 24.85 22.60 19.87 19.874
EV/Revenue 6.43 6.33 6.41 4.89 4.84 5.56 6.26 6.51 5.75 6.03 7.01 6.57 6.80 6.54 6.81 7.02 6.44 5.84 5.51 5.15 5.147
EV/EBIT 48.84 41.41 42.41 32.05 28.81 38.25 39.86 40.13 35.62 33.65 37.51 34.97 35.65 42.30 47.45 47.63 44.94 31.31 28.33 24.42 24.421
EV/FCF 35.55 39.55 45.54 41.74 43.07 50.40 52.32 52.38 44.49 39.41 51.41 50.11 46.61 42.36 44.21 41.55 38.58 34.23 30.47 28.28 28.285
Earnings Yield 2.0% 2.0% 2.0% 2.8% 3.3% 2.6% 2.5% 2.4% 2.5% 2.8% 2.5% 2.7% 2.6% 2.2% 2.0% 1.9% 2.1% 2.4% 2.6% 3.1% 3.07%
FCF Yield 3.1% 2.8% 2.5% 2.8% 2.7% 2.2% 2.1% 2.1% 2.5% 2.8% 2.1% 2.2% 2.3% 2.5% 2.5% 2.6% 2.8% 3.2% 3.6% 3.9% 3.87%
PEG Ratio snapshot only 1.140
EV/OCF snapshot only 24.071
EV/Gross Profit snapshot only 7.899
Acquirers Multiple snapshot only 23.369
Shareholder Yield snapshot only 1.21%
Graham Number snapshot only $116.22
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.13 2.20 1.98 2.00 2.04 1.63 1.73 1.54 1.48 1.58 1.71 1.68 1.91 1.95 1.64 1.78 1.85 1.89 2.11 2.16 2.157
Quick Ratio 1.35 1.47 1.18 1.15 1.19 1.00 0.99 0.84 0.83 0.97 0.99 0.95 1.22 1.32 1.00 1.06 1.13 1.21 1.25 1.33 1.331
Debt/Equity 0.92 0.87 0.97 0.88 0.80 0.81 0.80 0.77 0.74 0.73 0.70 0.64 0.79 0.68 0.83 0.81 0.80 0.66 0.66 0.62 0.623
Net Debt/Equity 0.73 0.66 0.87 0.81 0.71 0.70 0.70 0.69 0.63 0.56 0.57 0.55 0.56 0.47 0.71 0.69 0.65 0.48 0.53 0.48 0.478
Debt/Assets 0.38 0.37 0.40 0.38 0.37 0.37 0.37 0.36 0.35 0.34 0.34 0.33 0.37 0.33 0.38 0.37 0.37 0.31 0.33 0.31 0.312
Debt/EBITDA 4.12 3.58 4.07 3.78 3.31 3.67 3.40 3.22 3.11 2.87 2.71 2.53 3.06 3.11 3.95 3.72 3.76 2.52 2.47 2.23 2.233
Net Debt/EBITDA 3.29 2.74 3.64 3.48 2.93 3.15 2.96 2.86 2.65 2.22 2.22 2.14 2.17 2.12 3.40 3.18 3.04 1.82 1.99 1.71 1.713
Interest Coverage — — — — — — — — — — — — — — — 22.08 11.06 6.72 5.82 6.59 6.585
Equity Multiplier 2.41 2.33 2.40 2.30 2.19 2.22 2.18 2.15 2.12 2.15 2.06 1.98 2.18 2.08 2.20 2.19 2.16 2.13 2.01 2.00 1.998
Cash Ratio snapshot only 0.520
Debt Service Coverage snapshot only 8.092
Cash to Debt snapshot only 0.233
FCF to Debt snapshot only 0.315
Defensive Interval snapshot only 236.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.50 0.50 0.50 0.51 0.51 0.52 0.52 0.53 0.54 0.53 0.55 0.56 0.54 0.55 0.54 0.56 0.54 0.55 0.55 0.55 0.548
Inventory Turnover 1.83 1.90 1.89 1.89 1.94 2.04 1.95 1.88 1.80 1.81 1.74 1.72 1.67 1.81 1.74 1.74 1.71 1.82 1.74 1.67 1.665
Receivables Turnover 6.36 5.98 6.22 6.02 6.06 5.60 6.11 6.07 6.23 5.59 6.27 6.22 6.27 5.83 6.25 6.32 6.61 6.26 6.71 6.75 6.745
Payables Turnover 7.99 6.67 7.14 6.72 6.61 5.86 6.26 6.30 6.29 5.47 6.25 6.31 6.46 5.44 6.52 6.56 6.43 10.91 6.01 5.80 5.797
DSO 57 61 59 61 60 65 60 60 59 65 58 59 58 63 58 58 55 58 54 54 54.1 days
DIO 199 192 193 193 188 179 187 195 203 201 209 212 218 202 209 209 214 201 209 219 219.2 days
DPO 46 55 51 54 55 62 58 58 58 67 58 58 56 67 56 56 57 33 61 63 63.0 days
Cash Conversion Cycle 211 198 201 199 193 182 188 197 203 200 209 213 220 197 212 212 212 226 203 210 210.4 days
Fixed Asset Turnover snapshot only 5.768
Operating Cycle snapshot only 273.3 days
Cash Velocity snapshot only 7.433
Capital Intensity snapshot only 1.855
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 17.2% 19.2% 18.4% 8.5% 7.7% 7.8% 8.7% 10.4% 10.8% 11.1% 10.6% 9.9% 10.5% 10.2% 10.8% 11.4% 11.0% 11.2% 8.8% 8.5% 8.48%
Net Income 8.2% 24.7% 43.1% -0.2% 29.3% 18.3% 30.4% 30.3% 5.2% 34.2% 27.9% 27.3% 38.9% -5.4% -14.9% -15.4% -18.0% 8.5% 16.7% 27.8% 27.79%
EPS 7.5% 24.2% 42.7% -0.2% 29.6% 18.4% 30.2% 29.7% 4.6% 33.7% 27.3% 26.8% 38.3% -6.0% -15.2% -15.6% -18.3% 8.3% 16.7% 27.9% 27.93%
FCF 33.8% -1.9% -9.6% -30.5% -33.2% -25.6% -7.6% 16.9% 27.4% 54.0% 26.1% 16.0% 24.8% 11.2% 25.2% 43.6% 27.1% 22.8% 27.8% 16.8% 16.85%
EBITDA 5.6% 30.3% 37.0% 7.1% 26.1% 2.1% 11.1% 14.0% 6.1% 27.7% 24.0% 20.9% 23.3% -3.4% -11.2% -8.6% -10.8% 29.9% 40.2% 45.2% 45.16%
Op. Income 27.1% 24.3% 25.6% -0.1% -0.8% 2.3% 2.7% 7.9% 13.2% 16.2% 17.7% 15.4% 16.7% 16.0% 16.2% 18.2% 11.3% 12.0% 3.6% 5.2% 5.17%
OCF Growth snapshot only 15.93%
Asset Growth snapshot only 3.45%
Equity Growth snapshot only 13.20%
Debt Growth snapshot only -12.76%
Shares Change snapshot only -0.10%
Dividend Growth snapshot only 5.38%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 7.9% 7.9% 7.9% 7.5% 7.2% 7.4% 8.2% 11.4% 11.8% 12.6% 12.5% 9.6% 9.6% 9.7% 10.0% 10.6% 10.8% 10.8% 10.1% 9.9% 9.92%
Revenue 5Y 8.9% 8.6% 8.1% 8.1% 8.2% 8.2% 8.3% 8.3% 8.4% 8.5% 8.6% 8.5% 8.6% 8.7% 9.2% 11.1% 11.4% 11.8% 11.4% 9.7% 9.72%
EPS 3Y 15.2% -17.7% -17.2% -16.5% -10.6% 4.0% 6.4% 18.3% 13.4% 25.3% 33.3% 18.0% 23.3% 14.2% 12.0% 11.6% 5.8% 10.8% 8.0% 11.0% 11.04%
EPS 5Y 2.6% 3.7% 3.4% 4.0% 6.6% 18.2% 20.7% 20.0% 15.7% -2.5% -1.2% -0.9% 0.7% 7.2% 5.4% 12.1% 10.5% 14.9% 18.5% 12.1% 12.14%
Net Income 3Y 15.4% -17.5% -17.0% -16.3% -10.5% 4.2% 6.7% 19.2% 13.8% 25.6% 33.6% 18.3% 23.6% 14.5% 12.4% 12.0% 6.2% 11.2% 8.3% 11.2% 11.24%
Net Income 5Y 2.7% 3.9% 3.6% 4.1% 6.7% 18.2% 20.9% 20.2% 15.9% -2.3% -0.9% -0.6% 0.9% 7.5% 5.7% 12.8% 10.9% 15.2% 18.8% 12.4% 12.35%
EBITDA 3Y 1.9% 5.8% 6.3% 7.5% 10.0% 3.3% 4.9% 14.2% 12.2% 19.3% 23.6% 13.9% 18.1% 8.0% 7.0% 8.0% 5.3% 17.0% 15.6% 17.0% 17.04%
EBITDA 5Y 2.7% 5.8% 5.7% 7.4% 8.8% 6.9% 8.1% 7.5% 7.2% 9.1% 10.6% 11.4% 11.7% 6.3% 4.9% 10.5% 9.2% 16.4% 18.6% 14.4% 14.38%
Gross Profit 3Y 7.6% 7.6% 7.7% 7.0% 6.4% 5.9% 6.6% 11.1% 11.6% 13.0% 13.2% 9.1% 9.2% 9.3% 10.0% 11.0% 12.1% 13.2% 12.6% 13.1% 13.13%
Gross Profit 5Y 7.7% 7.7% 7.6% 7.4% 7.2% 7.1% 7.2% 7.4% 7.6% 7.9% 8.1% 8.2% 8.4% 8.4% 9.1% 11.8% 12.1% 13.1% 12.7% 10.8% 10.81%
Op. Income 3Y 8.1% 6.2% 6.3% 5.2% 4.1% 3.8% 4.6% 13.5% 12.6% 13.9% 15.0% 7.5% 9.4% 11.3% 12.0% 13.8% 13.7% 14.7% 12.3% 12.8% 12.79%
Op. Income 5Y 9.9% 9.1% 8.5% 7.1% 6.7% 6.9% 6.8% 6.9% 7.2% 7.3% 7.8% 7.7% 8.3% 8.5% 9.4% 14.8% 13.2% 13.9% 12.8% 9.1% 9.11%
FCF 3Y 22.5% 10.3% 6.1% 2.7% 2.0% 9.7% 8.0% 7.2% 4.4% 4.0% 1.8% -1.9% 2.0% 8.4% 13.4% 24.9% 26.4% 28.1% 26.3% 24.8% 24.83%
FCF 5Y 16.0% 15.2% 14.1% 7.9% 15.7% 16.2% 15.0% 17.1% 9.4% 9.0% 6.8% 8.0% 11.0% 17.7% 14.7% 15.5% 12.6% 9.0% 11.0% 9.6% 9.60%
OCF 3Y 16.0% 7.7% 4.7% 2.3% 1.6% 6.2% 5.1% 5.5% 4.7% 4.2% 3.4% 0.2% 3.1% 9.1% 12.5% 21.4% 22.6% 24.3% 23.3% 22.2% 22.24%
OCF 5Y 13.5% 12.2% 11.0% 6.5% 11.4% 11.0% 10.9% 12.2% 7.3% 7.3% 5.7% 6.5% 8.9% 14.1% 11.7% 13.1% 11.7% 9.0% 11.4% 10.2% 10.22%
Assets 3Y 15.6% 8.3% 11.7% 11.0% 10.5% 6.9% 7.8% 5.9% 5.6% 5.2% 5.6% 5.1% 8.7% 7.5% 8.4% 8.7% 9.4% 9.1% 7.9% 8.6% 8.61%
Assets 5Y 11.1% 11.1% 12.0% 11.1% 10.9% 10.7% 10.7% 11.6% 11.5% 7.9% 8.7% 8.2% 10.5% 7.3% 9.3% 8.0% 7.8% 6.9% 6.7% 7.3% 7.30%
Equity 3Y 12.9% 8.2% 8.8% 9.5% 10.2% 9.1% 8.8% 10.8% 11.3% 12.4% 12.4% 12.7% 12.4% 11.5% 11.6% 10.6% 9.8% 10.5% 10.8% 11.4% 11.38%
Book Value 3Y 12.6% 8.0% 8.4% 9.2% 10.0% 8.9% 8.5% 10.0% 10.9% 12.2% 12.1% 12.4% 12.1% 11.2% 11.3% 10.2% 9.3% 10.1% 10.5% 11.2% 11.18%
Dividend 3Y 3.2% 3.0% 2.9% 3.1% 3.2% 3.2% 3.0% 2.3% 2.6% 2.5% 2.3% 2.2% 2.1% 2.0% 1.8% 1.6% 1.5% 1.4% 1.5% 1.5% 1.54%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.92 0.89 0.90 0.94 0.92 0.90 0.91 0.94 0.93 0.92 0.92 0.98 0.97 0.97 0.98 1.00 1.00 1.00 1.00 0.99 0.993
Earnings Stability 0.06 0.02 0.01 0.04 0.07 0.01 0.03 0.07 0.08 0.00 0.01 0.04 0.07 0.72 0.60 0.80 0.77 0.90 0.81 0.81 0.807
Margin Stability 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.968
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.97 0.90 0.83 1.00 0.88 0.93 0.88 0.88 0.98 0.86 0.89 0.89 0.84 0.98 0.94 0.94 0.93 0.97 0.93 0.89 0.889
Earnings Smoothness 0.92 0.78 0.65 1.00 0.74 0.83 0.74 0.74 0.95 0.71 0.75 0.76 0.67 0.94 0.84 0.83 0.80 0.92 0.85 0.76 0.756
ROE Trend -0.07 -0.01 -0.00 -0.01 0.01 0.01 0.04 0.01 0.00 0.03 0.03 0.03 0.03 -0.01 -0.03 -0.03 -0.03 -0.01 -0.01 -0.00 -0.001
Gross Margin Trend 0.01 0.01 0.01 0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.03 0.035
FCF Margin Trend 0.04 0.01 -0.01 -0.04 -0.06 -0.07 -0.04 -0.03 -0.02 0.02 0.01 0.01 0.03 0.02 0.03 0.04 0.03 0.02 0.04 0.03 0.032
Sustainable Growth Rate 7.1% 7.5% 7.3% 7.3% 9.3% 8.3% 9.7% 9.8% 8.5% 11.5% 12.2% 12.2% 12.6% 9.0% 8.1% 8.1% 8.0% 9.1% 9.3% 10.7% 10.68%
Internal Growth Rate 3.0% 3.1% 3.1% 3.2% 4.3% 3.8% 4.4% 4.6% 4.1% 5.6% 6.1% 6.3% 6.2% 4.5% 4.0% 4.1% 3.8% 4.5% 4.6% 5.4% 5.39%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.84 1.64 1.50 1.28 1.07 1.11 1.09 1.12 1.23 1.17 1.03 0.99 1.07 1.42 1.50 1.63 1.64 1.55 1.61 1.48 1.482
FCF/OCF 0.86 0.84 0.81 0.78 0.77 0.78 0.79 0.80 0.81 0.85 0.82 0.82 0.83 0.82 0.83 0.84 0.84 0.85 0.85 0.85 0.851
FCF/Net Income snapshot only 1.261
OCF/EBITDA snapshot only 0.826
CapEx/Revenue 2.9% 3.1% 3.2% 3.4% 3.4% 3.2% 3.2% 3.1% 3.1% 2.8% 2.9% 2.9% 2.9% 3.3% 3.1% 3.1% 3.1% 3.0% 3.2% 3.2% 3.19%
CapEx/Depreciation snapshot only 0.661
Accruals Ratio -0.05 -0.04 -0.03 -0.02 -0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 0.00 -0.01 -0.03 -0.03 -0.04 -0.04 -0.04 -0.04 -0.04 -0.038
Sloan Accruals snapshot only 0.016
Cash Flow Adequacy snapshot only 2.582
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.0% 1.0% 1.0% 1.4% 1.4% 1.2% 1.0% 1.0% 1.1% 1.0% 0.9% 0.9% 0.9% 0.9% 0.9% 0.8% 0.9% 0.9% 1.0% 1.1% 1.17%
Dividend/Share $2.43 $2.48 $2.55 $2.62 $2.68 $2.75 $2.80 $2.85 $2.91 $2.97 $3.01 $3.06 $3.11 $3.16 $3.20 $3.24 $3.28 $3.32 $3.37 $3.41 $3.52
Payout Ratio 48.9% 47.6% 48.3% 48.1% 41.7% 44.6% 40.8% 40.4% 43.2% 36.0% 34.5% 34.2% 33.4% 40.7% 43.2% 42.9% 43.1% 39.6% 39.0% 35.3% 35.32%
FCF Payout Ratio 30.8% 34.7% 39.7% 48.4% 50.9% 51.6% 47.3% 45.3% 43.5% 36.3% 40.6% 42.1% 37.4% 35.0% 34.5% 31.1% 31.1% 30.0% 28.5% 28.0% 28.01%
Total Payout Ratio 55.2% 53.4% 54.9% 54.1% 46.4% 49.7% 46.3% 45.9% 49.2% 40.9% 39.7% 39.2% 38.4% 47.2% 49.6% 49.1% 49.2% 43.6% 44.1% 39.5% 39.50%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.12 0.11 0.11 0.12 0.12 0.12 0.11 0.10 0.10 0.09 0.09 0.09 0.08 0.08 0.07 0.07 0.07 0.06 0.06 0.06 0.064
Buyback Yield 0.1% 0.1% 0.1% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.13%
Net Buyback Yield 0.1% 0.1% 0.1% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.13%
Total Shareholder Return 1.1% 1.1% 1.1% 1.5% 1.5% 1.3% 1.1% 1.1% 1.2% 1.1% 1.0% 1.0% 1.0% 1.0% 1.0% 0.9% 1.0% 1.0% 1.2% 1.2% 1.21%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.87 0.87 0.88 0.88 0.92 0.88 0.88 0.86 0.81 0.86 0.86 0.86 0.86 0.86 0.86 0.87 0.88 0.72 0.73 0.72 0.724
Interest Burden (EBT/EBIT) 1.00 0.87 0.87 0.88 0.89 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.95 0.95 0.96 0.94 0.95 0.945
EBIT Margin 0.13 0.15 0.15 0.15 0.17 0.15 0.16 0.16 0.16 0.18 0.19 0.19 0.19 0.15 0.14 0.15 0.14 0.19 0.19 0.21 0.211
Asset Turnover 0.50 0.50 0.50 0.51 0.51 0.52 0.52 0.53 0.54 0.53 0.55 0.56 0.54 0.55 0.54 0.56 0.54 0.55 0.55 0.55 0.548
Equity Multiplier 2.45 2.47 2.44 2.36 2.29 2.27 2.28 2.22 2.15 2.18 2.11 2.06 2.15 2.11 2.13 2.09 2.17 2.11 2.10 2.09 2.086
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $4.96 $5.21 $5.27 $5.44 $6.44 $6.17 $6.86 $7.06 $6.73 $8.24 $8.73 $8.95 $9.31 $7.75 $7.40 $7.55 $7.61 $8.40 $8.63 $9.66 $9.66
Book Value/Share $37.05 $38.87 $39.32 $41.01 $43.12 $43.46 $44.09 $45.22 $46.63 $48.43 $49.78 $51.28 $52.25 $53.44 $54.17 $54.84 $56.34 $58.01 $59.45 $62.15 $62.55
Tangible Book/Share $-9.86 $-7.53 $-14.66 $-12.26 $-9.38 $-8.24 $-7.13 $-7.11 $-5.11 $-3.24 $-1.79 $-0.02 $-3.08 $0.99 $-11.11 $-10.23 $-8.58 $-6.60 $-4.46 $-3.47 $-3.47
Revenue/Share $43.56 $44.70 $45.54 $46.13 $47.01 $48.26 $49.46 $50.68 $51.78 $53.39 $54.44 $55.50 $56.99 $58.52 $60.09 $61.64 $63.05 $64.98 $65.38 $66.94 $67.37
FCF/Share $7.88 $7.15 $6.41 $5.41 $5.28 $5.33 $5.92 $6.30 $6.69 $8.17 $7.42 $7.27 $8.31 $9.03 $9.26 $10.41 $10.53 $11.08 $11.83 $12.18 $12.26
OCF/Share $9.15 $8.53 $7.88 $6.97 $6.86 $6.86 $7.48 $7.88 $8.30 $9.67 $9.01 $8.86 $9.96 $10.99 $11.10 $12.33 $12.50 $13.05 $13.91 $14.31 $14.41
Cash/Share $6.90 $7.89 $4.00 $2.95 $3.92 $5.04 $4.59 $3.85 $5.04 $7.95 $6.25 $5.08 $12.15 $11.64 $6.23 $6.38 $8.64 $10.61 $7.67 $9.01 $9.06
EBITDA/Share $8.28 $9.42 $9.38 $9.58 $10.47 $9.63 $10.41 $10.87 $11.04 $12.25 $12.85 $13.09 $13.55 $11.76 $11.37 $11.93 $12.06 $15.27 $15.94 $17.34 $17.34
Debt/Share $34.12 $33.71 $38.14 $36.24 $34.64 $35.38 $35.39 $35.00 $34.35 $35.15 $34.80 $33.07 $41.51 $36.57 $44.92 $44.33 $45.28 $38.45 $39.42 $38.71 $38.71
Net Debt/Share $27.22 $25.82 $34.15 $33.29 $30.72 $30.34 $30.80 $31.15 $29.30 $27.20 $28.55 $27.99 $29.36 $24.93 $38.68 $37.95 $36.64 $27.84 $31.74 $29.70 $29.70
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.790
Altman Z-Prime snapshot only 8.636
Piotroski F-Score 7 8 5 6 7 7 6 7 7 7 7 7 7 7 5 6 5 7 8 9 9
Beneish M-Score -2.44 -2.56 -2.44 -2.35 -2.34 -2.29 -2.46 -2.50 -2.53 -2.51 -2.42 -2.39 -2.36 -2.56 -2.46 -2.53 -2.64 -2.60 -2.79 -2.74 -2.741
Ohlson O-Score snapshot only -9.183
Net-Net WC snapshot only $-24.67
EVA snapshot only $576926923.08
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 80.23 82.75 78.81 79.45 79.39 80.79 78.78 79.81 78.03 82.40 81.77 82.48 81.31 81.97 80.30 84.52 81.59 78.49 80.61 81.05 81.047
Credit Grade snapshot only 4
Credit Trend snapshot only -3.472
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 79
Sector Credit Rank snapshot only 77

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms